Ascendis Pharma ADR
(ASND)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 667,694 | 669,879 | 328,155 | 220,805 | 199,552 |
| Marketable Securities | 153,386 | N/A | N/A | N/A | N/A |
| Receivables | 8,389 | 6,063 | 3,106 | 2,686 | 1,845 |
| TOTAL | $845,454 | $684,507 | $345,923 | $231,298 | $203,568 |
| Non-Current Assets | |||||
| PPE Net | 123,496 | 50,477 | 5,108 | 2,890 | 2,601 |
| Investments And Advances | 142,166 | 17,403 | 20,175 | 0 | 0 |
| Intangibles | 6,531 | 3,914 | 4,128 | 3,950 | 3,868 |
| Other Non-Current Assets | 1,571 | 1,639 | 1,368 | 331 | 297 |
| TOTAL | $273,764 | $73,433 | $30,778 | $7,172 | $6,765 |
| Total Assets | $1,119,218 | $757,940 | $376,701 | $238,470 | $210,333 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 25,013 | 46,048 | 37,800 | 26,865 | 14,472 |
| Other current liabilities | 27,126 | 961 | 8,151 | N/A | N/A |
| TOTAL | $60,318 | $53,749 | $45,962 | $26,865 | $14,893 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | N/A | 104 |
| Other Non-Current Liabilities | 100,840 | 35,423 | 0 | 0 | 0 |
| TOTAL | $100,840 | $35,423 | $N/A | $N/A | $N/A |
| Total Liabilities | $161,158 | $89,172 | $45,962 | $26,865 | $14,893 |
| Shareholders' Equity | |||||
| Common Shares | 8,244 | 7,216 | 6,683 | 5,614 | 4,818 |
| Retained earnings | -1,176,887 | -684,682 | -464,496 | -297,506 | 176,231 |
| Other shareholders' equity | 151,955 | 89,484 | 50,131 | 25,747 | 14,391 |
| TOTAL | $958,060 | $668,768 | $330,739 | $211,605 | $195,440 |
| Total Liabilities And Equity | $1,119,218 | $757,940 | $376,701 | $238,470 | $210,333 |